Business Wire

Uptime Institute Completes Acquisition of CNet Training, the International Award-Winning Technical Education Company

3.2.2023 16:01:00 EET | Business Wire | Press release

Share

Uptime Institute, the Global Digital Infrastructure Authority, a Dominus Capital, L.P. portfolio company, announced today that it has completed its acquisition of Academia Group Limited and all of its global subsidiaries including CNet Training, Ltd.

CNet Training, located in Bury Saint Edmunds, Suffolk, England, is an International award-winning technical education company. CNet Training has been designing and delivering professional network and data center infrastructure training programs since 1996 and has trained over 83,000 data center professionals across 45 countries.

“The data center industry is one of the fastest growing markets in the world. The continued, extraordinary industry expansion requires a growing and diverse workforce, however concerns over the industry’s ability to attract, educate, and retain skilled technical staff persist. This acquisition will help our respective customers thrive in a rapidly changing ecosystem, by giving them access to a range of world class corporate learning and development technical education programs that are backed up by practical experience and specialized domain expertise,” said Martin V. McCarthy, CEO, Uptime Institute.

CNet Training dramatically extends the range and depth of Uptime Education offerings and positions Uptime as the Learning & Development partner of choice around the world. The combined offerings will include solutions valuable for every point in a career for a digital infrastructure professional. This includes entry level staff, even adolescents in apprenticeships, to post graduate degrees in Data Center Leadership for savvy, long serving professionals.

“We are excited to join the accelerating Uptime team. CNet Training was already growing quickly, but now will have many more opportunities through further geographic expansion, and new service offerings, as a part of Uptime. As we look forward to this next phase, I want to personally thank all our clients, staff, and investors who have supported us over these past 26 + years of delivering unique value and in bringing ongoing innovation to the Digital Infrastructure Education market,” said Andrew Stevens, CEO of CNet Training.

Uptime Institute’s Intelligence team recently completed a market research study indicating the number of staff needed to design, build, and operate data centers will continue to grow globally from about 2.0 million in 2019 to nearly 2.3 million by 2025. A wide range of specialist jobs (230 detailed in Uptime Institute Data Center Career Pathfinder, developed in association with Google, Meta & Microsoft) are required by the sector to support its continued expansion. The combination of Uptime Institute and CNet Training will directly address the evolving training needs of all current and future data center employees as they progress through their careers.

Bob Haswell, Founding Partner at Dominus Capital, added, “This first acquisition for Uptime under Dominus ownership will further establish Uptime Education as the unparalleled leader in Digital Infrastructure Education around the world. Uptime is the undisputed market leader worldwide, with results-oriented solutions for both providers and consumers of services delivered through mission critical data center, the true digital foundries, and factories of the Internet economy. The ongoing availability, resiliency, sustainability, security, and business value of these key infrastructure building blocks still overwhelmingly depend on the quality and capabilities of the workforces that operate them, and the skill, training and education of each individual team member.”

Uptime Institute continues to identify and assess potential add-on acquisitions to broaden its offering and continue to execute on its mission to help data center owners, operators, and tenants ensure resilient, available, sustainable, and secure digital infrastructure.

About Uptime Institute

Uptime Institute is the Global Digital Infrastructure Authority. For over 25 years, the company has established industry-leading benchmarks for data center performance, resilience, sustainability, and efficiency, which provide customers assurance that their digital infrastructure can perform across a wide array of operating conditions at a level consistent with their business needs. Uptime’s Tier Standard is the IT industry’s most trusted and adopted global standard for the design, construction, and operation of data centers – the backbone of the digital economy. With its Tier Standard and Certifications, Management & Operations reviews, SCIRA-FSI financial sector risk assessment, broad range of additional risk and performance assessments, Intelligence research services, and accredited training courses completed by over 10,000 data center professionals, Uptime has helped thousands of companies in over 100 countries to optimize critical IT assets while managing costs, resources, and efficiency.

Uptime Institute is headquartered in New York, NY, with offices in London, Sao Paulo, Dubai, KSA Singapore, and Taipei. For more information, please visit www.uptimeinstitute.com.

About CNet Training

CNet Training (CNet) has been delivering technical education programs since 1996. Today CNet is the global leader in technical education for the digital infrastructure industry, comprising the data center and network infrastructure sectors and is the only industry dedicated education provider to award both internationally recognized qualifications and professional certifications. A significant part of CNet Training ’s history is the development of the highly acclaimed Global Digital Infrastructure Education Framework, which offers industry professionals an opportunity to plan technical education, qualifications, and certifications to meet on-going individual and business needs.

Since CNet’s inception it has delivered training across 218 delivery locations in 45 countries and in 19 time zones. Over 83,000 individuals of 153 different nationalities have accessed CNet Training’s technical education. For more information, please visit www.cnet-training.com

About Dominus Capital, L.P.

Based in New York, Dominus Capital is a leading middle-market private equity investment firm focused on management-led buyouts and growth capital investments in family-owned and founder-operated companies in the business services and light manufacturing sectors. Drawing on the experience, knowledge and network of its founders and a team of in-house operating executives, Dominus works hand-in-hand with exceptional management teams to unlock the untapped potential of its portfolio companies. Recently named one of the top 50 middle market private equity firms, Dominus takes a long-term approach to investing and has a consistent and highly successful track record of achieving significant growth at its portfolio companies. The Dominus team has executed more than 90 transactions over the past 20+ years. For more information, please visit www.dominuscap.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Brenda South, Uptime Institute
bsouth@uptimeinstitute.com
206-706-4647

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release

The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 12:52:00 EEST | Press release

The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not merely a wage dispute. It stems from deep structural concerns regarding the company’s ESG management, lack of operational autonomy, and passive labor relations. Primarily, the union highlighted unresolved corporate governance issues, including allegations concerning unfair labor practices and the unauthorized use of employee personal data, which were prominently reported by South Korea's major broadcaster, MBC, in November 2025. The union believes this crisis stems from management's failure to address r

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye